Inventor
TUMAN ROBERT W
US17 patents
⚠️ This page may combine multiple inventors who share the name “TUMAN ROBERT W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
8 patentsUS7795279B2Sep 14, 2010
Method of inhibiting FLT3 kinase
JANSSEN PHARMACEUTICA NV30 citations92
US8030305B2Oct 4, 2011
Triazolopyridazines as kinase modulators
JANSSEN PHARMACEUTICA NV24 citations91
US7662824B2Feb 16, 2010
Acylhydrazones as kinase modulators
JANSSEN PHARMACEUTICA NV2 citations60
US7208503B2Apr 24, 2007
Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
JANSSEN PHARMACEUTICA NV4 citations60
US6833369B2Dec 21, 2004
Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivatives
JANSSEN PHARMACEUTICA NV2 citations60
US6265407B1Jul 24, 2001
Angiogenesis inhibiting thiadiazolyl pyridazine derivatives
JANSSEN PHARMACEUTICA NV1 citations50
US7816390B2Oct 19, 2010
N-substituted tricyclic 3-aminopyrazoles as anti-mitotic tubulin polymerization inhibitors
JANSSEN PHARMACEUTICA NV0 citations48
US7795440B2Sep 14, 2010
N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
JANSSEN PHARMACEUTICA NV0 citations48
MCNEILAB INC
4 patentsUS5268373ADec 7, 1993
Guanidine derivatives, compositions and use
MCNEILAB INC5 citations61
US5294708AMar 15, 1994
Guanidine derivatives
MCNEILAB INC1 citations51
US4716163ADec 29, 1987
Hypoglycemic method using 5-substituted pyrrolidinylidene compounds
MCNEILAB INC0 citations42
US4670436AJun 2, 1987
Hypoglycemic 5-substituted pyrrolidinylidene compounds, compositions and use
MCNEILAB INC1 citations42